Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Operating Income (2022 - 2025)

Incannex Healthcare's Operating Income history spans 3 years, with the latest figure at -$7.0 million for Q4 2025.

  • On a quarterly basis, Operating Income fell 39.79% to -$7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.3 million, a 7.38% increase, with the full-year FY2025 number at -$23.8 million, up 20.81% from a year prior.
  • Operating Income hit -$7.0 million in Q4 2025 for Incannex Healthcare, down from -$6.8 million in the prior quarter.
  • Over the last five years, Operating Income for IXHL hit a ceiling of -$4.9 million in Q3 2023 and a floor of -$9.7 million in Q2 2024.
  • Historically, Operating Income has averaged -$6.8 million across 3 years, with a median of -$6.9 million in 2025.
  • Biggest five-year swings in Operating Income: soared 37.32% in 2024 and later plummeted 39.79% in 2025.
  • Tracing IXHL's Operating Income over 3 years: stood at -$8.0 million in 2023, then soared by 37.32% to -$5.0 million in 2024, then tumbled by 39.79% to -$7.0 million in 2025.
  • Business Quant data shows Operating Income for IXHL at -$7.0 million in Q4 2025, -$6.8 million in Q3 2025, and -$7.5 million in Q2 2025.